STOCKWATCH
·
 Medicinal Chemicals and Botanical Products
Quarterly ResultMay 14, 2026, 04:14 PM

Mannatech Q1 Net Income $0.95M; EPS $0.49

AI Summary

Mannatech Inc. reported a significant turnaround in its first quarter of 2026, achieving a net income of $0.95 million, or $0.49 per diluted share, compared to a net loss of $1.53 million, or $(0.80) per diluted share, in the prior year. Despite a decrease in net sales to $24.92 million from $26.56 million, the company improved its loss from operations and generated positive cash flow from operating activities. Cash and cash equivalents also increased to $7.01 million by quarter-end.

Key Highlights

  • Net income was $0.95 million for Q1 2026, a significant improvement from a $(1.53) million loss in Q1 2025.
  • Diluted EPS reached $0.49 in Q1 2026, up from $(0.80) per share in Q1 2025.
  • Net sales decreased to $24.92 million in Q1 2026 from $26.56 million in Q1 2025.
  • Loss from operations improved to $(0.18) million in Q1 2026 from $(0.83) million in Q1 2025.
  • Net cash provided by operating activities was $1.13 million in Q1 2026, compared to $(1.37) million used in Q1 2025.
  • Cash and cash equivalents increased to $7.01 million as of March 31, 2026, from $6.19 million at December 31, 2025.
  • Working capital stood at $1.73 million as of March 31, 2026.
MTEX
Medicinal Chemicals and Botanical Products
MANNATECH INC

Price Impact